Related Experiment Video
Updated: May 13, 2025

06:24
Mouse Models of Periventricular Leukomalacia
Published on: May 18, 2010
29.7K
[Neurological Peroxisomal Disorders with a Focus on Adrenoleukodystrophy]
1Division of Genomics Research, Life Science Research Center, Gifu University.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 12, 2025
Summary
Early diagnosis of peroxisomal neurological diseases, like adrenoleukodystrophy, is crucial. Prompt identification enables effective treatments, improving outcomes for patients with these rare hereditary conditions.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Peroxisomal disorders encompass a range of hereditary neurological conditions.
- Adrenoleukodystrophy (ALD) is a significant example, with early diagnosis critical for effective treatment.
- Recent advances in genetic analysis reveal peroxisomal diseases in adults presenting with symptoms like cerebellar ataxia.
Purpose of the Study:
- To emphasize the importance of early diagnosis in peroxisomal neurological diseases.
- To highlight the critical window for intervention in conditions like adrenoleukodystrophy.
- To discuss the evolving landscape of peroxisomal disease identification in adult populations.
Main Methods:
- Review of current literature on peroxisomal disorders and neurological manifestations.
- Analysis of the impact of large-scale genetic analyses on disease identification.
- Focus on diagnostic strategies for early detection of hereditary neurological conditions.
Main Results:
- Early hematopoietic stem cell transplantation shows efficacy in adrenoleukodystrophy, including adult cerebral forms.
- Expanded genetic screening has identified previously undiagnosed peroxisomal diseases in adults.
- Cerebellar ataxia is a recognized symptom in adult-onset peroxisomal neurological disorders.
Conclusions:
- Early diagnosis of peroxisomal neurological diseases is paramount for timely and effective therapeutic interventions.
- Advances in genetic technologies are expanding the recognition of these disorders in adult patients.
- A proactive diagnostic approach is essential for managing the neurological impact of peroxisomal disorders.
Related Concept Videos
Protein Import into the Peroxisomes
3.3K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.3K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Inborn Errors of Metabolism
109
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
109
Smooth Endoplasmic Reticulum
5.3K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
5.3K

